Ehab Mattar

Dr. Ehab Mattar

Assistant professor Department Of Biology college of science King Abdulaziz University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
AJArif Tasleem Jan
Arif Tasleem Jan
SRSafikur Rahman
Safikur Rahman
RBRaied Badierah
Raied Badierah
ELEun Ju Lee
Eun Ju Lee
EMEhab Mattar
Ehab Mattar
ICInho Choi
Inho Choi
Exosomes are membrane-enclosed distinct cellular entities of endocytic origin that shuttle proteins and RNA molecules intercellularly for communication purposes. Their surface is embossed by a huge variety of proteins, some of which are used as diagnostic markers. Exosomes are being explored for potential drug delivery, although their therapeutic utilities are impeded by gaps in knowledge regarding their formation and function under physiological condition and by lack of methods capable of shedding light on intraluminal vesicle release at the target site. Nonetheless, exosomes offer a promising means of developing systems that enable the specific delivery of therapeutics in diseases like cancer. This review summarizes information on donor cell types, cargoes, cargo loading, routes of administration, and the engineering of exosomal surfaces for specific peptides that increase target specificity and as such, therapeutic delivery.

20 October 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MKMajid Rasool Kamli
Majid Rasool Kamli
MMMaqsood Malik
Maqsood Malik
VSVartika Srivastava
Vartika Srivastava
JSJamal Sabir
Jamal Sabir
EMEhab Mattar
Ehab Mattar
AAAijaz Ahmad
Aijaz Ahmad
This study presents an inexpensive, eco-friendly, and simple green synthesis of ZnO nanoparticles using Origanum vulgare extract. These nanoparticles are non-hazardous, environmentally friendly, and cheaper than other methods of biosynthesis. Ongoing research determines the role of phytochemicals in the fabrication and biosynthesis of ZnO NPs and their role in antibacterial activity and biomedical applications. Characterizations by fourier transform infrared spectroscopy (FTIR), diffuse reflectance UV-visible spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) determine the successful biosynthesis of ZnO NPs. Meanwhile, TEM and X-ray diffraction studies approximated the spherical morphology and crystalline nature of biosynthesized ZnO NPs of nano size in the range of 20–30 nm. The global increase in drug resistance necessitates the search for new drugs with different mechanisms of action. Quorum sensing (QS), a cell-to-cell communication, has gained attention as an emerging drug target. It controls numerous biochemical processes in bacteria, which are essential for their survival and pathogenicity. The potential of nanomedicines has also been tested to synthesize new antibiotics to tackle drug resistance. ZnO NPs were explored for their antibacterial, antiquorum sensing, and antibiofilm activities with a bioreporter strain of Chromobacterium violaceum. Susceptibility testing results indicated the potential antibacterial activity of ZnO NPs with a minimum inhibitory concentration (MIC) of 4 µg/mL and minimum bactericidal concentration (MBC) of 16 µg/mL. Antiquorum-sensing assays revealed that these nanoparticles inhibit quorum sensing with minimum antiquorum sensing activity (MQSIC) of 1 µg/mL, without causing any bacterial growth inhibition. In addition, ZnO NPs inhibit biofilm formation at inhibitory and higher concentrations. RT-qPCR results supported the downregulation of the quorum sensing genes when C. violaceum was treated with ZnO NPs. The outcomes of this study are promising with regard to the biofilm and quorum sensing, emphasizing the potential applications of ZnO NPs against bacterial communication and biofilm formation.

18 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MKMajid Rasool Kamli
Majid Rasool Kamli
MMMaqsood Malik
Maqsood Malik
SLShabir Ahmad Lone
Shabir Ahmad Lone
JSJamal Sabir
Jamal Sabir
EMEhab Mattar
Ehab Mattar
AAAijaz Ahmad
Aijaz Ahmad
Beta vulgaris extract contains water-soluble red pigment betanin and is used as a food colorant. In this study, the biogenic Ag-Cu bimetallic nanoparticles were synthesized and characterized by different spectroscopic and microscopic techniques, including UV–Visible, FTIR, TEM. SEM-EDX, XRD, and TGA. Further, Ag-Cu bimetallic nanoparticles capped with Beta vulgaris biomolecules were evaluated for their antifungal activity against Candida albicans via targeting its major virulence factors, including adherence, yeast to hyphae transition, extracellular enzyme secretion, biofilm formation, and the expression of genes related to these pathogenic traits by using standard methods. C. albicans is an opportunistic human fungal pathogen that causes significant morbidity and mortality, mainly in immunocompromised patients. The current antifungal therapy is limited with various shortcomings such as host toxicity and developing multidrug resistance. Therefore, the development of novel antifungal agents is urgently required. Furthermore, NPs were screened for cell viability and cytotoxicity effect. Antifungal susceptibility testing showed potent antifungal activity of the Ag-Cu bimetallic NPs with a significant inhibitory effect on adherence, yeast to hyphae transition, extracellular enzymes secretion, and formation of biofilms in C. albicans at sub-inhibitory and inhibitory concentrations. The RT-qPCR results at an MIC value of the NPs exhibited a varying degree of downregulation in expression levels of virulence genes. Results also revealed the dose-dependent effect of NPs on cellular viability (up to 100%) using MUSE cell analyzer. Moreover, the low cytotoxicity effect of bimetallic NPs has been observed using haemolytic assay. The overall results indicated that the newly synthesized Ag-Cu bimetallic NPs capped with Beta vulgaris are proven to possess a potent anticandidal activity, by affecting the vital pathogenic factors of C. albicans.

26 January 2025 in Antibodies
Verified
Journal Article
Open access
PDF file
MAMOHAMMED ALGHAMDI
MOHAMMED ALGHAMDI
SBSami Mohammed Bahlas
Sami Mohammed Bahlas
SASultan Abdulmughni Alamry
Sultan Abdulmughni Alamry
EMEhab Mattar
Ehab Mattar
ERElrashdy M. Redwan
Elrashdy M. Redwan
Background: Autoantibodies such as rheumatoid factor (RF) and anticitrullinated protein autoantibodies (ACPAs) are useful tools for rheumatoid arthritis (RA). The presence of ACPAs against citrullinated proteins (CPs), especially citrullinated fibrinogen (cFBG), seems to be a useful serological marker for diagnosing RA. RA patients’ sera were found to be enriched in exosomes that can transmit many proteins. Exosomes have been found to express citrullinated protein such as cFBG. Objective: We conducted this study in two stages. In the first phase, we aimed to evaluate the association between autoantibodies and risk factors. In the next step, ACPA-positive serum samples from the first phase were subjected to exosomal studies to explore the presence of cFBG, which is a frequent target for ACPAs. Methods: We investigated the autoantibodies in one hundred and sixteen Saudi RA patients and correlated with host-related risk factors. Exosomes were extracted from patients’ sera and examined for the presence of cFBG using monoclonal antibodies. Results: The study reported a high female-to-male ratio of 8:1, and seropositive RA (SPRA) was more frequent among included RA patients. The frequency and the levels of ACPAs were similar in both genders. Autoantibodies incidences have a direct correlations with patient age, while the average titers decreased as the age increased. Further, the highest incidence and levels of autoantibodies were reported in patients with RA duration between 5 and 10 years. Smoking and family history have no impact on autoantibody, except for ACPAs titers among smokers’ RA. Our analysis of serum exosomes revealed that about 50% of SPRA patients expressed cFBG. Conclusions: The female-to-male ratio is 8:1, which is higher than the global ratio. We can conclude that patients’ age and disease duration contribute to the autoantibodies, particularly RF and anti-MCV, whereas smoking and family history had no effects on autoantibodies. We detected cFBG in all exosomes from SPRA patients; thus, we suggest that the precise mechanism of exosomes in RA pathogenesis can be investigated to develop effective treatment strategies.

10 November 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Alkathiri
Abdulrahman Alkathiri
EMEhab Mattar
Ehab Mattar
AHAnwar Hashem
Anwar Hashem
ERElrashdy M. Redwan
Elrashdy M. Redwan
Vaccine adjuvants enhance immune responses and improve the effectiveness of veterinary vaccines. However, their performance and safety vary across animal species, vaccine formulations, and production systems. This narrative review examines the historical development, mechanisms, applications, safety, and regulatory considerations of major veterinary adjuvant classes. Aluminum salts are widely used because of their affordability and ability to enhance antibody responses, although their effects on cellular immunity may be limited. Oil-based emulsions can provide strong and durable immune responses, particularly in inactivated vaccines for livestock and poultry, but injection-site reactions and formulation stability remain important concerns. Saponin-based systems can stimulate both antibody and cellular immunity, with applications in equine and canine vaccines. Polymeric nanoparticles and pattern-recognition receptor agonists offer promising approaches for mucosal vaccination and targeted immune activation, although further validation in veterinary species is needed. Adjuvant selection must consider antigen properties, species-specific immune responses, age, administration route, protective efficacy, manufacturing feasibility, and regulatory requirements. Future research should prioritize comparative studies in target species, predictive biomarkers, improved vaccine stability, and evaluation of complete antigen–adjuvant formulations. These considerations may support the development of safer, more effective, and practical veterinary vaccines.

2 November 2026 in Molecules
Verified
Journal Article
Open access
PDF file
HAHassan Alarjani
Hassan Alarjani
NANawaf S. Alsulami
Nawaf S. Alsulami
HAHanan A Alshamrani
Hanan A Alshamrani
EMEhab Mattar
Ehab Mattar
ARAlberto Rubio-Casillas
Alberto Rubio-Casillas
ERElrashdy M. Redwan
Elrashdy M. Redwan
Akkermansia muciniphila is a next-generation probiotic linked to intestinal barrier integrity and host metabolic well-being. However, the mechanisms underlying its mucin utilization remain incompletely understood. In particular, the temporal hierarchy of enzyme deployment, the subcellular and extracellular-vesicle localization of individual mucin-degrading enzymes (MDEs), the fine substrate specificity of glycoside hydrolases toward distinct O-glycan linkages, and the strain-dependent differences in mucinolytic capacity have yet to be resolved. This review integrates genomic, biochemical, and metabolic data to show how A. muciniphila mucin-degrading enzymes (MDEs) degrade mucus, releasing nutrients that support A. muciniphila growth and fermentation (acetate and propionate) and cross-feeding by other bacteria, including butyrate producers. It also highlights that A. muciniphila exhibits a dual nature: it safely stimulates regulated mucus degradation, improves barrier integrity, and feeds beneficial microbes. In contrast, in specific experimental contexts, such as fiber-deprived or high-sugar murine models, dietary fiber shortage or metabolic stress has been associated with increased mucus degradation, a thinner mucus layer, and greater susceptibility to inflammation and pathogens. The probiotic effects of A. muciniphila against metabolic and inflammatory conditions may involve regulated mucin degradation, but benefits may also arise from mechanisms beyond active mucin degradation, including bacterial surface proteins and pasteurized preparations. Unlocking the safe therapeutic potential of this bacterium requires mapping out the spatial, temporal, and strain-specific details of these enzymes. Future research should combine multi-omics and host-interaction studies to clarify enzyme hierarchy, vesicle delivery, and context-dependent impacts.